148 related articles for article (PubMed ID: 32547068)
1. Anti-PD-1 Therapy Achieved Disease Control After Multiline Chemotherapy in Unresectable
Chen L; Han X; Gao Y; Zhao Q; Wang Y; Jiang Y; Liu S; Wu X; Miao L
Onco Targets Ther; 2020; 13():4359-4364. PubMed ID: 32547068
[TBL] [Abstract][Full Text] [Related]
2. Hepatoid adenocarcinoma of the lung with PD-L1 expression and the response to anti-PD-1 therapy: a case report.
Li Y; Liu L; Wang D; Tan X; Sui Y; Yang H
Front Oncol; 2023; 13():1257931. PubMed ID: 38074660
[TBL] [Abstract][Full Text] [Related]
3. Alpha-fetoprotein-producing hepatoid adenocarcinoma of the lung responsive to sorafenib after multiline treatment: A case report.
Xu SZ; Zhang XC; Jiang Q; Chen M; He MY; Shen P
World J Clin Cases; 2022 Oct; 10(28):10236-10243. PubMed ID: 36246828
[TBL] [Abstract][Full Text] [Related]
4. Genomic Profiles of a Patient of Pulmonary Hepatoid Adenocarcinoma With High AFP Level: A Case Report.
Li J; Qi H; Xu B; Zhao J; Gao H; Ma X; Liu X
Front Oncol; 2019; 9():1360. PubMed ID: 31921629
[TBL] [Abstract][Full Text] [Related]
5. Hepatoid Adenocarcinoma of the Lung.
Li M; Fan Y; Lu H
Technol Cancer Res Treat; 2021; 20():15330338211057983. PubMed ID: 34816785
[TBL] [Abstract][Full Text] [Related]
6. Hepatoid adenocarcinoma of the lung without production of α-fetoprotein: A case report and review of the literature.
Sun JN; Zhang BL; Li LK; Yu HY; Wang B
Oncol Lett; 2016 Jul; 12(1):189-194. PubMed ID: 27347123
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics of Hepatoid adenocarcinoma of the lung: Four case reports and literature review.
Zhuansun Y; Bian L; Zhao Z; Du Y; Chen R; Lin L; Li J
Cancer Treat Res Commun; 2021; 29():100474. PubMed ID: 34656923
[TBL] [Abstract][Full Text] [Related]
8. Hepatoid Adenocarcinoma of the Lung: A Systematic Review of the Literature From 1981 to 2020.
Hou Z; Xie J; Zhang L; Dai G; Chen Y; He L
Front Oncol; 2021; 11():702216. PubMed ID: 34422656
[TBL] [Abstract][Full Text] [Related]
9. A novel approach using sorafenib in alpha fetoprotein-producing hepatoid adenocarcinoma of the lung.
Gavrancic T; Park YH
J Natl Compr Canc Netw; 2015 Apr; 13(4):387-91; quiz 391. PubMed ID: 25870375
[TBL] [Abstract][Full Text] [Related]
10. Hepatoid Adenocarcinoma of the Lung Responsive to Frontline Combination Chemotherapy With Immunotherapy: Case Report.
Lagos GG; Feldman JL; Saqi A; Shu CA
JTO Clin Res Rep; 2021 Feb; 2(2):100130. PubMed ID: 34589989
[TBL] [Abstract][Full Text] [Related]
11. Merged hepatopulmonary features in hepatoid adenocarcinoma of the lung: a systematic review.
Mao JX; Liu C; Zhao YY; Ding GS; Ma JQ; Teng F; Guo WY
Am J Transl Res; 2021; 13(3):898-922. PubMed ID: 33841629
[TBL] [Abstract][Full Text] [Related]
12. Primary Hepatoid Adenocarcinoma of the Lung: A Systematic Literature Review.
Chen Z; Ding C; Zhang T; He Y; Jiang G
Onco Targets Ther; 2022; 15():609-627. PubMed ID: 35676912
[TBL] [Abstract][Full Text] [Related]
13. Primary hepatoid adenocarcinoma of the lung in Yungui Plateau, China: A case report.
Shi YF; Lu JG; Yang QM; Duan J; Lei YM; Zhao W; Liu YQ
World J Clin Cases; 2019 Jul; 7(13):1711-1716. PubMed ID: 31367631
[TBL] [Abstract][Full Text] [Related]
14. Whole-exome sequencing and bioinformatics analysis of a case of non-alpha-fetoprotein-elevated lung hepatoid adenocarcinoma.
Yao Y; Guan X; Bao G; Liang J; Li T; Zhong X
Front Pharmacol; 2022; 13():945038. PubMed ID: 36091765
[TBL] [Abstract][Full Text] [Related]
15. Hepatoid Adenocarcinoma of the Lung: A Review of the Most Updated Literature and a Presentation of Three Cases.
Bonis A; Dell'Amore A; Verzeletti V; Melan L; Zambello G; Nardocci C; Comacchio GM; Pezzuto F; Calabrese F; Rea F
J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36835946
[TBL] [Abstract][Full Text] [Related]
16. Pathologic complete response of hepatoid adenocarcinoma of the stomach after chemo-immunotherapy: A rare case report and literature review.
Zhou Y; Dong L; Dai L; Hu S; Sun Y; Wu Y; Pan T; Li X
Front Surg; 2023; 10():1133335. PubMed ID: 37065996
[TBL] [Abstract][Full Text] [Related]
17. Hepatoid Adenocarcinoma of the Stomach: A Challenging Diagnostic and Therapeutic Disease through a Case Report and Review of the Literature.
Fakhruddin N; Bahmad HF; Aridi T; Yammine Y; Mahfouz R; Boulos F; Awada A; Farhat F
Front Med (Lausanne); 2017; 4():164. PubMed ID: 29034239
[TBL] [Abstract][Full Text] [Related]
18. Effect of mutant variants of the KRAS gene on PD-L1 expression and on the immune microenvironment and association with clinical outcome in lung adenocarcinoma patients.
Falk AT; Yazbeck N; Guibert N; Chamorey E; Paquet A; Ribeyre L; Bence C; Zahaf K; Leroy S; Marquette CH; Cohen C; Mograbi B; Mazières J; Hofman V; Brest P; Hofman P; Ilié M
Lung Cancer; 2018 Jul; 121():70-75. PubMed ID: 29858030
[TBL] [Abstract][Full Text] [Related]
19. KRAS mutation-induced upregulation of PD-L1 mediates immune escape in human lung adenocarcinoma.
Chen N; Fang W; Lin Z; Peng P; Wang J; Zhan J; Hong S; Huang J; Liu L; Sheng J; Zhou T; Chen Y; Zhang H; Zhang L
Cancer Immunol Immunother; 2017 Sep; 66(9):1175-1187. PubMed ID: 28451792
[TBL] [Abstract][Full Text] [Related]
20. Hepatoid adenocarcinoma of the lung: report of a case of an unusual alpha-fetoprotein-producing lung tumor.
Arnould L; Drouot F; Fargeot P; Bernard A; Foucher P; Collin F; Petrella T
Am J Surg Pathol; 1997 Sep; 21(9):1113-8. PubMed ID: 9298890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
